Market Cap 5.76M
Revenue (ttm) 0.00
Net Income (ttm) -13.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 75,900
Avg Vol 294,840
Day's Range N/A - N/A
Shares Out 2.77M
Stochastic %K 12%
Beta 0.99
Analysts Strong Sell
Price Target $25.00

Company Profile

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pipeline includes NGC-Cap (PCS6422), a combination of PCS6422 and capecitabine, whi...

Industry: Biotechnology
Sector: Healthcare
Phone: 772 453 2899
Fax: 443 288 4420
Address:
601 21st Street, Suite 300, Vero Beach, United States
TheTarkioTrader
TheTarkioTrader Aug. 22 at 7:35 PM
$ADVB $CVAT $MOVE $PCSA $SONM The underlying deal is real — it’s in CVAT’s SEC filing — but the “10.8¢ locked in, 270% return” framing leaves out some key details. The offer price isn’t fixed: it’s calculated as Net Price ÷ shares outstanding, and that gets recalculated at a record date 45 business days after the tender offer even opens, so the final per-share number can still move. The deal also isn’t done — EGS needs at least 90% of shares tendered, plus a separate $7M side-deal for Alchemy Beverages has to close too. And this plays out over months, not days, with the offer staying open 60+ business days and another 30+ after final pricing is set. The gap between the 3-6¢ trading price and the 10¢+ deal price isn’t free money sitting on the table — it’s the market pricing in real risk that this doesn’t close cleanly. Legit news, just not the guaranteed windfall it’s being sold as.
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 22 at 7:28 PM
$CVAT Cavitation Technologies has execute a buyout for this company at 35 million $. This translate to 10.8c per share, you can finds this on the company SEC filing. The stock right now trades 3.9c, the buyout is for 10.8c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 10.8c Current sp: 3.9c 270% Return on Investment, Tender will start Monday!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! https://www.compuserve.com/pf/story/0022/20260817/9811028.htm $MOVE $SONM $ADVB $PCSA
0 · Reply
Schizoo
Schizoo Aug. 21 at 3:44 PM
$PCSA swing this
0 · Reply
Schizoo
Schizoo Aug. 20 at 7:01 PM
$PCSA low float.. high short.. hold...
0 · Reply
Schizoo
Schizoo Aug. 20 at 1:09 PM
$PCSA spreas is big today.. 9.24 and 13.02 🤷‍♂️🤌
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 12:42 PM
$PCSA gl flying soon buy back incoming
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 19 at 3:07 PM
$LSTA Agreed w/ post below @Biotech_Pharma_Investor! As confirmed by Kuva CEO yesterday via email they are still actively working on putting together a fully funded offer. This option is not dead yet, but even if it is and RM is the solution, we are still in a safe zone imo. 10Q shows 10m cash end of June 30, 2026. 1.2m in costs with workforce reduction, and burn of 3-4m in GA expenses puts this at 5m cash end of Sept 30, 2026. Likely has 7m in cash today + NASDAQ shell worth 7-10m. In an RM scenario the likely value would be 3m cash + NASDAQ shell = 10m or 1.10/share FLOOR valuation, giving ZERO value to assets. The math still supports the current PPS imo If anyone needs convincing, take a look at $PCSA which had negative cash (weeks away from BK) and just completed a RM transaction and is trading at 6m mc. NASDAQ shells have a lot more value than people like to admit!
0 · Reply
Schizoo
Schizoo Aug. 18 at 2:39 PM
$PCSA repeating pattern.. should gp back to 2.70+ and next time 3+?
0 · Reply
Schizoo
Schizoo Aug. 17 at 7:59 PM
$PCSA swiiiiing
1 · Reply
Schizoo
Schizoo Aug. 17 at 5:29 PM
$PCSA swing this..
0 · Reply
Latest News on PCSA
Processa Pharmaceuticals Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 9 days ago

Processa Pharmaceuticals Quarterly report: Q2 2026


Processa Pharmaceuticals Transcript: M&A announcement

Jul 29, 2026, 8:30 AM EDT - 25 days ago

Processa Pharmaceuticals Transcript: M&A announcement


Processa Pharmaceuticals Press release: M&A announcement

Jul 29, 2026, 8:30 AM EDT - 25 days ago

Processa Pharmaceuticals Press release: M&A announcement


Processa Pharmaceuticals Slides: M&A announcement

Jul 29, 2026, 8:30 AM EDT - 25 days ago

Processa Pharmaceuticals Slides: M&A announcement


Processa Pharmaceuticals Proxy statement: Proxy filing

Jun 18, 2026, 8:00 AM EDT - 2 months ago

Processa Pharmaceuticals Proxy statement: Proxy filing


Processa Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Processa Pharmaceuticals Quarterly report: Q1 2026


Processa Pharmaceuticals Annual report: Q4 2025

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Processa Pharmaceuticals Annual report: Q4 2025


Processa Pharmaceuticals provides update on Phase 2 NGS-Cap

2025-12-17T13:05:52.000Z - 8 months ago

Processa Pharmaceuticals provides update on Phase 2 NGS-Cap


Processa Pharmaceuticals Inc trading halted, news pending

2025-12-17T00:50:10.000Z - 8 months ago

Processa Pharmaceuticals Inc trading halted, news pending


Processa Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 2:00 AM EST - 10 months ago

Processa Pharmaceuticals Quarterly report: Q3 2025


Processa Pharmaceuticals Proxy statement: Proxy Filing

Aug 25, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Aug 13, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 3:00 AM EDT - 1 year ago

Processa Pharmaceuticals Quarterly report: Q2 2025


Processa Pharmaceuticals Proxy statement: Proxy Filing

Jul 31, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Transcript: Status Update

Jul 9, 2025, 4:15 PM EDT - 1 year ago

Processa Pharmaceuticals Transcript: Status Update


Processa terminates license agreement for PCS3117

2025-07-01T13:10:33.000Z - 1 year ago

Processa terminates license agreement for PCS3117


Processa sells 28M shares at 25c in public offering

2025-06-17T16:35:07.000Z - 1 year ago

Processa sells 28M shares at 25c in public offering


Processa sees 28M shares at 25c in public offering

2025-06-17T16:30:08.000Z - 1 year ago

Processa sees 28M shares at 25c in public offering


Processa Pharmaceuticals Proxy statement: Proxy Filing

May 12, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

May 12, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 6:00 PM EDT - 1 year ago

Processa Pharmaceuticals Quarterly report: Q1 2025


Processa Pharmaceuticals Proxy statement: Proxy Filing

May 1, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Slides: Investor presentation

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals Slides: Investor presentation


Processa Pharmaceuticals Annual report: Q4 2024

Mar 20, 2025, 3:00 AM EDT - 1 year ago

Processa Pharmaceuticals Annual report: Q4 2024


Processa Pharmaceuticals prices $5M at-the-market offering

2025-01-28T12:21:04.000Z - 1 year ago

Processa Pharmaceuticals prices $5M at-the-market offering


Processa Pharmaceuticals Earnings release: Q3 2024

Oct 30, 2024, 3:00 AM EDT - 1 year ago

Processa Pharmaceuticals Earnings release: Q3 2024


Processa Pharmaceuticals Quarterly report: Q3 2024

Oct 30, 2024, 3:00 AM EDT - 1 year ago

Processa Pharmaceuticals Quarterly report: Q3 2024


Processa Pharmaceuticals jumps 28% after Phase 2 study update

2024-10-02T21:00:35.000Z - 2 years ago

Processa Pharmaceuticals jumps 28% after Phase 2 study update


Processa Pharmaceuticals Slides: Investor presentation

Aug 26, 2024, 7:00 AM EDT - 2 years ago

Processa Pharmaceuticals Slides: Investor presentation


Processa Pharmaceuticals Earnings release: Q2 2024

Aug 13, 2024, 3:00 AM EDT - 2 years ago

Processa Pharmaceuticals Earnings release: Q2 2024


Processa Pharmaceuticals Quarterly report: Q2 2024

Aug 13, 2024, 3:00 AM EDT - 2 years ago

Processa Pharmaceuticals Quarterly report: Q2 2024


Processa Pharmaceuticals Proxy statement: Proxy Filing

Jun 11, 2024, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Quarterly report: Q1 2024

May 10, 2024, 3:00 AM EDT - 2 years ago

Processa Pharmaceuticals Quarterly report: Q1 2024


Processa Pharmaceuticals Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Slides: Corporate presentation

Apr 3, 2024, 7:00 AM EDT - 2 years ago

Processa Pharmaceuticals Slides: Corporate presentation


Processa Pharmaceuticals Annual report: Q4 2023

Mar 29, 2024, 3:00 AM EDT - 2 years ago

Processa Pharmaceuticals Annual report: Q4 2023


Processa Pharmaceuticals Slides: Corporate presentation

Jan 11, 2024, 7:00 AM EST - 2 years ago

Processa Pharmaceuticals Slides: Corporate presentation


Processa Pharmaceuticals Slides: FY 2023

Dec 5, 2023, 7:00 AM EST - 2 years ago

Processa Pharmaceuticals Slides: FY 2023


Processa Pharmaceuticals Quarterly report: Q3 2023

Nov 13, 2023, 2:00 AM EST - 3 years ago

Processa Pharmaceuticals Quarterly report: Q3 2023


Processa Pharmaceuticals Slides: Corporate presentation

Oct 11, 2023, 7:00 AM EDT - 3 years ago

Processa Pharmaceuticals Slides: Corporate presentation


Processa Pharmaceuticals Proxy statement: Proxy Filing

Oct 5, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Oct 5, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Sep 25, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Quarterly report: Q2 2023

Aug 10, 2023, 3:00 AM EDT - 3 years ago

Processa Pharmaceuticals Quarterly report: Q2 2023


Processa Pharmaceuticals Slides: FY 2023

May 23, 2023, 7:00 AM EDT - 3 years ago

Processa Pharmaceuticals Slides: FY 2023


Processa Pharmaceuticals Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Processa Pharmaceuticals Quarterly report: Q1 2023


Processa Pharmaceuticals Proxy statement: Proxy Filing

May 1, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

May 1, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


Processa Pharmaceuticals Proxy statement: Proxy Filing

Apr 14, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals Proxy statement: Proxy Filing


TheTarkioTrader
TheTarkioTrader Aug. 22 at 7:35 PM
$ADVB $CVAT $MOVE $PCSA $SONM The underlying deal is real — it’s in CVAT’s SEC filing — but the “10.8¢ locked in, 270% return” framing leaves out some key details. The offer price isn’t fixed: it’s calculated as Net Price ÷ shares outstanding, and that gets recalculated at a record date 45 business days after the tender offer even opens, so the final per-share number can still move. The deal also isn’t done — EGS needs at least 90% of shares tendered, plus a separate $7M side-deal for Alchemy Beverages has to close too. And this plays out over months, not days, with the offer staying open 60+ business days and another 30+ after final pricing is set. The gap between the 3-6¢ trading price and the 10¢+ deal price isn’t free money sitting on the table — it’s the market pricing in real risk that this doesn’t close cleanly. Legit news, just not the guaranteed windfall it’s being sold as.
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 22 at 7:28 PM
$CVAT Cavitation Technologies has execute a buyout for this company at 35 million $. This translate to 10.8c per share, you can finds this on the company SEC filing. The stock right now trades 3.9c, the buyout is for 10.8c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 10.8c Current sp: 3.9c 270% Return on Investment, Tender will start Monday!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! https://www.compuserve.com/pf/story/0022/20260817/9811028.htm $MOVE $SONM $ADVB $PCSA
0 · Reply
Schizoo
Schizoo Aug. 21 at 3:44 PM
$PCSA swing this
0 · Reply
Schizoo
Schizoo Aug. 20 at 7:01 PM
$PCSA low float.. high short.. hold...
0 · Reply
Schizoo
Schizoo Aug. 20 at 1:09 PM
$PCSA spreas is big today.. 9.24 and 13.02 🤷‍♂️🤌
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 12:42 PM
$PCSA gl flying soon buy back incoming
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 19 at 3:07 PM
$LSTA Agreed w/ post below @Biotech_Pharma_Investor! As confirmed by Kuva CEO yesterday via email they are still actively working on putting together a fully funded offer. This option is not dead yet, but even if it is and RM is the solution, we are still in a safe zone imo. 10Q shows 10m cash end of June 30, 2026. 1.2m in costs with workforce reduction, and burn of 3-4m in GA expenses puts this at 5m cash end of Sept 30, 2026. Likely has 7m in cash today + NASDAQ shell worth 7-10m. In an RM scenario the likely value would be 3m cash + NASDAQ shell = 10m or 1.10/share FLOOR valuation, giving ZERO value to assets. The math still supports the current PPS imo If anyone needs convincing, take a look at $PCSA which had negative cash (weeks away from BK) and just completed a RM transaction and is trading at 6m mc. NASDAQ shells have a lot more value than people like to admit!
0 · Reply
Schizoo
Schizoo Aug. 18 at 2:39 PM
$PCSA repeating pattern.. should gp back to 2.70+ and next time 3+?
0 · Reply
Schizoo
Schizoo Aug. 17 at 7:59 PM
$PCSA swiiiiing
1 · Reply
Schizoo
Schizoo Aug. 17 at 5:29 PM
$PCSA swing this..
0 · Reply
HDTech
HDTech Aug. 17 at 4:26 PM
$PCSA Acquisition and pipeline expansion: In July 2026 Processa completed the acquisition of Vidya, adding BTK inhibitor VT-7208 and advancing multi-indication Phase 2 programs. Funding for operations: The company raised $200M gross in a private placement tied to the Vidya acquisition to fund VT-7208 trials into the second half of 2029. Clinical milestones and timelines: Targeted Phase 2 proof-of-concept data windows include food allergy in H2 2027, chronic spontaneous urticaria (CSU) in H1 2028, and relapsing multiple sclerosis (RMS) in H2 2028. Program rationalization: Processa returned PCS6422 to Elion and closed the related Phase 2 breast cancer trial following a settlement to focus resources on core assets. Expenses: R&D spending declined due to a paused NGC-Cap trial, while G&A increased driven by higher professional fees and insurance as operations scale post-acquisition.
0 · Reply
HDTech
HDTech Aug. 17 at 4:26 PM
$PCSA Processa Pharmaceuticals, Inc. reported third-quarter results for the period ended June 30, 2026, posting a net loss of $(3.27M) and diluted loss per share of $(1.19).
0 · Reply
Schizoo
Schizoo Aug. 17 at 4:15 PM
$PCSA same pattern again.. swing this.
0 · Reply
Luckyizme
Luckyizme Aug. 15 at 1:44 PM
$PCSA Er Aug 17? Also, need to see good VT-7208 clinical results for next catalyst to making this to fly to .
1 · Reply
AI4all
AI4all Aug. 12 at 3:09 PM
$PCSA the Big crash is coming
0 · Reply
Schizoo
Schizoo Aug. 12 at 1:39 PM
$PCSA 🤌😘
0 · Reply
ckjamesst
ckjamesst Aug. 11 at 5:18 PM
$FRTT $INHD $GAME $PCSA Flying flying buy buy hold hold $FRTT I’ve been buying crazy under 1 now it’s our turn to flip the chart injecting another 20k around 3-4 buck till then just staying in profit Hold hold buy buy 12-+ Squeez incoming
0 · Reply
Schizoo
Schizoo Aug. 10 at 4:52 PM
$PCSA 🤌😘
0 · Reply
chinchinbull
chinchinbull Aug. 10 at 1:36 PM
Am movers $PCSA Vs $SCKT Vs $JWEL Vs $ZJYL
0 · Reply
Tetoooo
Tetoooo Aug. 10 at 1:23 PM
$PCSA if it gaps down most likely it won't fill the gap same day based on FinPile.ai
1 · Reply
Schizoo
Schizoo Aug. 10 at 1:09 PM
$PCSA hold..
0 · Reply
chinchinbull
chinchinbull Aug. 7 at 8:20 PM
After hours on move $PCSA is moving vs $HUDI $GYGY VS $RYOJ
0 · Reply